-
The company says the new system is three times faster than the original iVue model
-
The researchers believe the technology, which uses nanoparticles to deliver an RUNX1 inhibitor, could have applications in treating diseases relating to sight loss
-
AEYE Health CEO, Zack Dvey-Aharon, speaks to OT about the company’s AI handheld fundus camera and its aim to make screening more accessible
-
A gene therapy company reported results from a study involving patients with x-linked retinitis pigmentosa at the Euretina 2020 Virtual Congress
-
The technology incorporates nanowire light sensors that mimic the photoreceptors in the human retina
-
The importance of patients seeking timely treatment has been reinforced by an anecdotal rise in patients ignoring symptoms during lockdown
-
Scientists report promising results from a study that aims to develop a new approach to treating the most common inherited eye condition
-
Researchers used gene therapy to successfully activate degenerated photoreceptors in mice
-
Professor Lyndon da Cruz follows in the footsteps of Kylie Minogue, Professor Germaine Greer and Clive James